Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK1 | Q13464 | 12/20 | 0.78 |
| ▸ | ROCK2 | O75116 | 12/20 | 0.78 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.52 |
| ▸ | TSPO | P30536 | 2/20 | 0.45 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1649557 | 0.88 | ROCK1 (0.76) | ROCK1ROCK2HSD17B2TSPOABHD6 | |
| SCHEMBL1649564 | 0.87 | ROCK1 (1.00) | ROCK1ROCK2 | |
| SCHEMBL1647543 | 0.85 | ROCK1 (0.78) | ROCK1ROCK2HPGD | |
| SCHEMBL1647880 | 0.76 | ROCK1 (1.00) | ROCK1ROCK2 | |
| SCHEMBL12779552 | 0.75 | ROCK2 (0.77) | ROCK1ROCK2HSD17B2ABHD6 | |
| SCHEMBL1647892 | 0.74 | ROCK2 (0.78) | ROCK1ROCK2 | |
| SCHEMBL1649554 | 0.73 | ROCK2 (1.00) | ROCK1ROCK2 | |
| SCHEMBL1649562 | 0.73 | ROCK1 (0.66) | ROCK1ROCK2 | |
| SCHEMBL12779204 | 0.70 | ROCK2 (0.79) | ROCK1ROCK2HSD17B2 | |
| SCHEMBL1647895 | 0.70 | ROCK2 (0.59) | ROCK1ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011050245-A1 | BICYCLIC HETEROARYLS AS KINASE INHIBITORS | FENG YANGBO (US) | 2011-04-28 | — | — | WO | disclosed |
| WO-2011050245-A1 | BICYCLIC HETEROARYLS AS KINASE INHIBITORS | FENG YANGBO (US) | 2011-04-28 | — | — | WO | disclosed |